Sign in or create an account to add this stock to your watchlist.
MAXIMUS, Inc. provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews. Its services include health insurance exchange customer contact center operations and support; health insurance program eligibility and enrollment; beneficiary outreach and education; application assistance and independent health plan enrollment counseling; premium payment processing and administration; eHealth solutions; independent disability, long-term sick, and health assessments; occupational health clinical assessments; and specialized program consulting services. The company's U.S. Federal Services segment offers services, including centralized customer contact centers and support services; documents and records management; and case management, citizen engagement, and consumer education; independent medical reviews and worker's compensation benefit appeals; health benefit appeals; eligibility appeals; modernization of systems and IT infrastructure; infrastructure operations and support; software development, operations, and management; and data analytics. Its Human Services segment provides national, state, and local human services agencies with various BPS and related consulting services for welfare-to-work, child support, and higher education; and management tools and professional consulting, program consulting, and tax credit and employer services. MAXIMUS, Inc. was founded in 1975 and is headquartered in Reston, Virginia.
Industry, Sector and Symbol
Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
Trailing P/E Ratio20.31
Forward P/E Ratio18.99
Sales & Book Value
Annual Sales$2.45 billion
Price / Sales1.64
Cash Flow$4.1358 per share
Price / Cash14.88
Book Value$16.34 per share
Price / Book3.77
EPS (Most Recent Fiscal Year)$3.03
Net Income$209.42 million
Return on Equity21.67%
Return on Assets15.50%
Maximus (NYSE:MMS) Frequently Asked Questions
What is Maximus' stock symbol?
Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."
How often does Maximus pay dividends? What is the dividend yield for Maximus?
Maximus declared a quarterly dividend on Wednesday, April 11th. Stockholders of record on Tuesday, May 15th will be given a dividend of $0.045 per share on Thursday, May 31st. This represents a $0.18 annualized dividend and a dividend yield of 0.29%. The ex-dividend date is Monday, May 14th. View Maximus' Dividend History.
How were Maximus' earnings last quarter?
Maximus Inc. (NYSE:MMS) released its earnings results on Thursday, May, 10th. The health services provider reported $0.82 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.84 by $0.02. The health services provider had revenue of $612.79 million for the quarter, compared to the consensus estimate of $617.97 million. Maximus had a net margin of 9.15% and a return on equity of 21.67%. The company's revenue was down 1.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.80 EPS. View Maximus' Earnings History.
What guidance has Maximus issued on next quarter's earnings?
Maximus updated its FY18 earnings guidance on Thursday, May, 10th. The company provided earnings per share (EPS) guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.
What price target have analysts set for MMS?
3 analysts have issued 1-year target prices for Maximus' stock. Their forecasts range from $64.00 to $81.00. On average, they expect Maximus' share price to reach $69.50 in the next twelve months. View Analyst Ratings for Maximus.
Who are some of Maximus' key competitors?
Some companies that are related to Maximus include TSYS (TSS), MSCI (MSCI), Worldpay (WP), Mercadolibre (MELI), CoStar Group (CSGP), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), Cielo (CIOXY), Alliance Data (ADS), Zillow (Z), Zillow (ZG), Nielsen (NLSN), Western Union (WU), Grubhub (GRUB) and CDK Global (CDK).
Who are Maximus' key executives?
Maximus' management team includes the folowing people:
- Mr. Bruce L. Caswell, Pres, CEO & Director (Age 51)
- Mr. Richard J. Nadeau, CFO & Treasurer (Age 63)
- Mr. David R. Francis, Gen. Counsel & Sec. (Age 57)
- Mr. Mark S. Andrekovich, Chief of Human Capital and Pres of Tax & Employer Services (Age 56)
- Mr. Kelly L. Clark, Chief Information Officer
Has Maximus been receiving favorable news coverage?
News coverage about MMS stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Maximus earned a media sentiment score of 0.07 on Accern's scale. They also gave media coverage about the health services provider an impact score of 47.24 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
Who are Maximus' major shareholders?
Maximus' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.51%), Victory Capital Management Inc. (5.20%), Bamco Inc. NY (4.27%), Van Berkom & Associates Inc. (1.84%), Northern Trust Corp (1.69%) and Mondrian Investment Partners LTD (1.42%). Company insiders that own Maximus stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau, Russell A Beliveau and Wellington E Webb. View Institutional Ownership Trends for Maximus.
Which institutional investors are selling Maximus stock?
MMS stock was sold by a variety of institutional investors in the last quarter, including Bamco Inc. NY, Boston Partners, Schwab Charles Investment Management Inc., WCM Investment Management CA, Comerica Bank, Elk Creek Partners LLC, Alambic Investment Management L.P. and Envestnet Asset Management Inc.. Company insiders that have sold Maximus company stock in the last year include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for Maximus.
Which institutional investors are buying Maximus stock?
MMS stock was bought by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, P2 Capital Partners LLC, Thompson Siegel & Walmsley LLC, Mondrian Investment Partners LTD, BlackRock Inc., Handelsbanken Fonder AB, Handelsbanken Fonder AB and Wells Fargo & Company MN. Company insiders that have bought Maximus stock in the last two years include Anne K Altman and Richard John Nadeau. View Insider Buying and Selling for Maximus.
How do I buy shares of Maximus?
Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Maximus' stock price today?
One share of MMS stock can currently be purchased for approximately $61.54.
How big of a company is Maximus?
Maximus has a market capitalization of $4.02 billion and generates $2.45 billion in revenue each year. The health services provider earns $209.42 million in net income (profit) each year or $3.03 on an earnings per share basis. Maximus employs 20,400 workers across the globe.
How can I contact Maximus?
Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]
MarketBeat Community Rating for Maximus (MMS)MarketBeat's community ratings are surveys of what our community members think about Maximus and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
Maximus (NYSE:MMS) Price Target and Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
3 Wall Street analysts have issued ratings and price targets for Maximus in the last 12 months. Their average twelve-month price target is $69.50, suggesting that the stock has a possible upside of 12.93%. The high price target for MMS is $81.00 and the low price target for MMS is $64.00. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold."
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Hold||Hold||Hold|
|Consensus Rating Score: ||2.00||2.00||2.00||2.00|
|Ratings Breakdown: ||0 Sell Rating(s)|
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
5 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$69.50||$65.50||$65.50||$62.60|
|Price Target Upside: ||12.93% upside||2.47% upside||2.47% upside||1.06% downside|
Maximus (NYSE:MMS) Consensus Price Target History
Maximus (NYSE:MMS) Analyst Ratings History
(Data available from 5/27/2016 forward)
Maximus (NYSE:MMS) Dividend Information
Maximus pays an annual dividend of $0.18 per share, with a dividend yield of 0.29%. MMS's next quarterly dividend payment will be made on Thursday, May 31. Maximus pays out 5.94% of its earnings out as a dividend.
|Dividend Growth:||-9.10% (3 Year Average)|
|Payout Ratio(s):||5.94% (Trailing 12 Months of Earnings) |
5.56% (Based on This Year's Estimates)
5.08% (Based on Next Year's Estimates)
4.35% (Based on Cash Flow)
Maximus (NYSE:MMS) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Maximus (NYSE MMS) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.10%
Institutional Ownership Percentage: 93.07%
Maximus (NYSE MMS) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|4/2/2018||Russell A Beliveau||Director||Sell||1,000||$66.55||$66,550.00|| |
|2/22/2018||Richard A Montoni||CEO||Sell||30,000||$67.89||$2,036,700.00|| |
|2/20/2018||Richard A Montoni||CEO||Sell||10,000||$67.42||$674,200.00|| |
|2/13/2018||David Francis||General Counsel||Sell||3,600||$64.50||$232,200.00||10,017|| |
|1/2/2018||Russell A Beliveau||Director||Sell||1,000||$71.73||$71,730.00|| |
|12/15/2017||Mark Andrekovich||Insider||Sell||2,700||$72.00||$194,400.00||20,296|| |
|12/7/2017||Richard A Montoni||CEO||Sell||30,000||$69.25||$2,077,500.00|| |
|12/5/2017||Mark Andrekovich||Insider||Sell||5,000||$68.80||$344,000.00||22,996|| |
|12/5/2017||Richard A Montoni||CEO||Sell||10,000||$69.04||$690,400.00|| |
|11/30/2017||Raymond B Ruddy||Director||Sell||10,350||$68.89||$713,011.50|| |
|11/22/2017||Mark Andrekovich||Insider||Sell||5,594||$67.23||$376,084.62||27,996|| |
|11/17/2017||David Francis||General Counsel||Sell||1,373||$65.35||$89,725.55||13,617|| |
|11/15/2017||Russell A Beliveau||Director||Sell||1,500||$64.30||$96,450.00||40,329|| |
|11/13/2017||David Francis||General Counsel||Sell||3,900||$63.97||$249,483.00||15,090|| |
|10/5/2017||David Francis||General Counsel||Sell||3,000||$65.28||$195,840.00|| |
|9/27/2017||Raymond B Ruddy||Director||Sell||25,000||$65.12||$1,628,000.00||226,652|| |
|9/18/2017||Bruce Caswell||President||Sell||8,000||$63.28||$506,240.00||35,904|| |
|9/11/2017||Raymond B Ruddy||Director||Sell||25,000||$62.68||$1,567,000.00||227,552|| |
|9/5/2017||Bruce Caswell||President||Sell||8,000||$60.23||$481,840.00||35,904|| |
|8/18/2017||David Francis||General Counsel||Sell||2,000||$58.89||$117,780.00||13,716|| |
|8/17/2017||Richard A Montoni||CEO||Sell||29,203||$60.38||$1,763,277.14||549,215|| |
|8/16/2017||Bruce Caswell||President||Sell||8,000||$60.50||$484,000.00||35,904|| |
|8/16/2017||Raymond B Ruddy||Director||Sell||25,000||$60.39||$1,509,750.00||252,552|| |
|8/14/2017||Paul R Lederer||Director||Sell||2,200||$60.87||$133,914.00|| |
|8/10/2017||Bruce Caswell||President||Sell||8,000||$59.83||$478,640.00||35,904|| |
|7/27/2017||Bruce Caswell||President||Sell||8,000||$60.97||$487,760.00||35,904|| |
|7/14/2017||David Francis||General Counsel||Sell||1,000||$60.46||$60,460.00||15,715|| |
|7/12/2017||Bruce Caswell||President||Sell||8,000||$62.21||$497,680.00||35,904|| |
|6/23/2017||David Francis||General Counsel||Sell||1,000||$63.15||$63,150.00||16,715|| |
|6/16/2017||Bruce Caswell||President||Sell||8,000||$63.56||$508,480.00||35,904|| |
|6/9/2017||Mark Andrekovich||Insider||Sell||8,939||$64.01||$572,185.39||24,583|| |
|6/5/2017||Bruce Caswell||President||Sell||8,000||$63.48||$507,840.00||35,904|| |
|6/2/2017||David Francis||General Counsel||Sell||1,000||$62.70||$62,700.00||17,715|| |
|5/25/2017||Richard A Montoni||CEO||Sell||30,000||$62.81||$1,884,300.00||584,114|| |
|5/23/2017||Bruce Caswell||President||Sell||8,000||$62.76||$502,080.00||35,904|| |
|5/18/2017||Bruce Caswell||President||Sell||8,000||$61.79||$494,320.00||35,904|| |
|5/16/2017||Russell A Beliveau||Director||Sell||1,500||$63.82||$95,730.00||41,829|| |
|5/12/2017||David Francis||General Counsel||Sell||1,000||$63.14||$63,140.00||18,716|| |
|5/11/2017||Bruce Caswell||President||Sell||17,197||$62.47||$1,074,296.59||27,904|| |
|5/9/2017||Paul R Lederer||Director||Sell||8,210||$61.83||$507,624.30||51,984|| |
|4/20/2017||David Francis||General Counsel||Sell||1,500||$59.91||$89,865.00||19,716|| |
|3/31/2017||David Francis||General Counsel||Sell||1,500||$62.40||$93,600.00||21,216|| |
|3/31/2017||Raymond B Ruddy||Director||Sell||8,500||$62.57||$531,845.00||279,477|| |
|3/30/2017||Raymond B Ruddy||Director||Sell||9,500||$62.53||$594,035.00||286,052|| |
|3/10/2017||David Francis||General Counsel||Sell||1,500||$60.36||$90,540.00||22,716|| |
|3/9/2017||Richard A Montoni||CEO||Sell||30,000||$60.59||$1,817,700.00||614,114|| |
|2/21/2017||Mark Andrekovich||Insider||Sell||5,620||$58.86||$330,793.20||38,080|| |
|2/17/2017||David Francis||General Counsel||Sell||1,500||$59.08||$88,620.00||24,216|| |
|2/10/2017||Anne K Altman||Director||Buy||2,700||$56.04||$151,308.00||2,700|| |
|12/15/2016||David Francis||General Counsel||Sell||1,901||$55.00||$104,555.00||25,716|| |
|12/15/2016||Mark Andrekovich||Insider||Sell||2,455||$54.87||$134,705.85||39,513|| |
|11/25/2016||Richard A Montoni||CEO||Sell||25,000||$57.00||$1,425,000.00||641,114|| |
|11/17/2016||David Francis||General Counsel||Sell||2,000||$55.00||$110,000.00||27,616|| |
|11/11/2016||Richard John Nadeau||CFO||Buy||1,000||$50.10||$50,100.00||10,256|| |
|10/14/2016||David Francis||General Counsel||Sell||2,000||$55.00||$110,000.00||29,616|| |
|9/22/2016||Bruce Caswell||President||Sell||20,000||$56.99||$1,139,800.00||36,386|| |
|9/1/2016||David Francis||General Counsel||Sell||1,500||$58.69||$88,035.00||21,936|| |
|8/26/2016||Paul R Lederer||Director||Sell||500||$59.15||$29,575.00||74,674|| |
|8/25/2016||Richard A Montoni||CEO||Sell||25,000||$58.70||$1,467,500.00||620,282|| |
|8/18/2016||Bruce Caswell||President||Sell||30,000||$58.98||$1,769,400.00||39,386|| |
|8/1/2016||David Francis||General Counsel||Sell||1,500||$58.91||$88,365.00||23,436|| |
|7/14/2016||Raymond B Ruddy||Director||Sell||18,000||$60.00||$1,080,000.00||295,552|| |
|7/1/2016||David Francis||General Counsel||Sell||1,500||$55.07||$82,605.00||24,936|| |
|6/22/2016||Bruce Caswell||President||Sell||30,000||$56.34||$1,690,200.00||39,386|| |
|6/21/2016||Bruce Caswell||President||Sell||10,000||$56.59||$565,900.00||39,386|| |
|6/20/2016||Bruce Caswell||President||Sell||10,000||$55.56||$555,600.00||39,386|| |
|6/6/2016||Wellington E. Webb||Director||Sell||560||$56.95||$31,892.00|| |
|6/2/2016||Russell A Beliveau||Director||Sell||1,000||$57.47||$57,470.00||44,479|| |
|6/1/2016||David Francis||General Counsel||Sell||1,500||$56.83||$85,245.00||26,436|| |
|5/19/2016||Richard A Montoni||CEO||Sell||25,000||$54.02||$1,350,500.00||645,282|| |
|5/17/2016||Paul R Lederer||Director||Sell||6,750||$54.78||$369,765.00||75,174|| |
|3/1/2016||Russell A Beliveau||Director||Sell||1,000||$49.35||$49,350.00||44,479|| |
|12/1/2015||Russell A Beliveau||Director||Sell||1,000||$56.81||$56,810.00||45,579|| |
|11/18/2015||Peter Pond||Director||Buy||14,375||$52.27||$751,381.25||14,375|| |
|11/13/2015||Richard John Nadeau||CFO||Buy||1,000||$53.16||$53,160.00||6,889|| |
|10/9/2015||Bruce Caswell||President||Sell||20,000||$61.80||$1,236,000.00||29,386|| |
|9/1/2015||Russell A Beliveau||Director||Sell||1,000||$59.58||$59,580.00||46,579|| |
|8/20/2015||Richard A Montoni||CEO||Sell||25,000||$62.00||$1,550,000.00|| |
|8/13/2015||Bruce Caswell||President||Sell||20,000||$59.94||$1,198,800.00|| |
|7/24/2015||Bruce Caswell||President||Sell||20,000||$68.03||$1,360,600.00|| |
|6/17/2015||Bruce Caswell||President||Sell||20,000||$63.00||$1,260,000.00|| |
|6/16/2015||Bruce Caswell||President||Sell||7,000||$62.61||$438,270.00|| |
|6/15/2015||Bruce Caswell||President||Sell||7,000||$62.31||$436,170.00|| |
|5/13/2015||Bruce Caswell||President||Sell||20,000||$62.96||$1,259,200.00|| |
|4/22/2015||Bruce Caswell||President||Sell||6,000||$66.92||$401,520.00|| |
|4/21/2015||Bruce Caswell||President||Sell||7,000||$66.26||$463,820.00|| |
|4/20/2015||Bruce Caswell||President||Sell||7,000||$65.74||$460,180.00|| |
|3/16/2015||David Francis||General Counsel||Sell||2,300||$64.09||$147,407.00|| |
|3/16/2015||Marilyn R Seymann||Director||Sell||2,802||$63.00||$176,526.00|| |
|3/3/2015||Mark Andrekovich||Insider||Sell||3,722||$60.00||$223,320.00|| |
|3/2/2015||Russell A Beliveau||Director||Sell||1,000||$59.43||$59,430.00|| |
|2/26/2015||Mark Andrekovich||Insider||Sell||3,185||$60.00||$191,100.00|| |
|2/26/2015||Paul R Lederer||Director||Sell||1,275||$59.65||$76,053.75|| |
|2/19/2015||Paul R Lederer||Director||Sell||3,060||$59.08||$180,784.80|| |
|2/19/2015||Richard A Montoni||CEO||Sell||25,000||$58.89||$1,472,250.00|| |
|2/17/2015||Marilyn R Seymann||Director||Sell||2,806||$59.60||$167,237.60|| |
|2/12/2015||David Francis||General Counsel||Sell||3,100||$59.08||$183,148.00|| |
|2/6/2015||Mark Andrekovich||Insider||Sell||3,093||$60.00||$185,580.00|| |
|1/23/2015||Mark Andrekovich||Insider||Sell||10,000||$57.00||$570,000.00|| |
|1/15/2015||Marilyn R Seymann||Director||Sell||2,806||$56.00||$157,136.00|| |
|12/24/2014||Mark Andrekovich||Insider||Sell||10,000||$55.02||$550,200.00|| |
|12/15/2014||Marilyn R Seymann||Director||Sell||2,806||$51.38||$144,172.28|| |
|12/3/2014||Paul R Lederer||Director||Sell||1,300||$53.61||$69,693.00|| |
|12/1/2014||Russell A Beliveau||Director||Sell||1,000||$52.31||$52,310.00|| |
|11/20/2014||Richard A Montoni||CEO||Sell||25,000||$51.76||$1,294,000.00|| |
|11/18/2014||Paul R Lederer||Director||Sell||6,250||$52.09||$325,562.50|| |
|11/17/2014||Marilyn R Seymann||Director||Sell||2,806||$52.55||$147,455.30|| |
|11/14/2014||Mark Andrekovich||Insider||Sell||15,000||$52.78||$791,700.00|| |
|10/30/2014||David Francis||General Counsel||Sell||19,340||$46.50||$899,310.00|| |
|10/28/2014||Akbar Piloti||Insider||Sell||23,740||$45.00||$1,068,300.00|| |
|9/15/2014||Marilyn R Seymann||Director||Sell||2,806||$41.33||$115,971.98|| |
|9/2/2014||Russell A Beliveau||Director||Sell||1,000||$41.29||$41,290.00|| |
|8/18/2014||Marilyn R Seymann||Director||Sell||2,806||$40.05||$112,380.30|| |
|8/18/2014||Richard A Montoni||CEO||Sell||25,000||$40.04||$1,001,000.00|| |
|7/15/2014||Marilyn R Seymann||Director||Sell||2,806||$41.79||$117,262.74|| |
|7/3/2014||Bruce Caswell||Insider||Sell||25,000||$1,397.09||$34,927,250.00|| |
|6/16/2014||Marilyn R Seymann||Director||Sell||2,806||$42.34||$118,806.04|| |
|6/12/2014||Bruce Caswell||Insider||Sell||25,000||$43.31||$1,082,750.00|| |
|6/2/2014||Russell A Beliveau||Director||Sell||1,000||$44.38||$44,380.00|| |
|5/22/2014||Richard Montoni||CEO||Sell||24,000||$42.70||$1,024,800.00||626,200|| |
|5/21/2014||Bruce Caswell||Insider||Sell||25,000||$42.62||$1,065,500.00||1|| |
|5/13/2014||Russell Beliveau||Director||Sell||10,000||$43.23||$432,300.00||53,179|| |
|4/23/2014||Bruce Caswell||Insider||Sell||25,000||$42.50||$1,062,500.00||1|| |
|4/2/2014||Bruce Caswell||Insider||Sell||18,799||$44.67||$839,751.33||1|| |
|4/1/2014||Akbar Piloti||Insider||Sell||3,290||$45.00||$148,050.00||13,878|| |
|4/1/2014||Russell Beliveau||Director||Sell||1,000||$44.92||$44,920.00||63,179|| |
|2/28/2014||John Haley||Director||Sell||5,316||$48.81||$259,473.96|| |
|2/25/2014||Bruce Caswell||Insider||Sell||7,000||$48.11||$336,770.00||17,134|| |
|2/24/2014||Bruce Caswell||Insider||Sell||7,000||$47.30||$331,100.00||24,135|| |
|2/24/2014||David Francis||General Counsel||Sell||1,205||$47.76||$57,550.80||13,129|| |
|2/21/2014||Bruce Caswell||Insider||Sell||7,000||$47.17||$330,190.00||31,135|| |
|2/19/2014||Paul Lederer||Director||Sell||8,550||$47.01||$401,935.50||88,530|| |
|2/14/2014||Raymond Ruddy||Director||Sell||31,364||$46.96||$1,472,853.44||313,552|| |
|2/13/2014||Richard Montoni||CEO||Sell||24,000||$47.09||$1,130,160.00||633,750|| |
|2/12/2014||Raymond Ruddy||Director||Sell||31,364||$47.24||$1,481,635.36||344,916|| |
|2/7/2014||David Walker||CFO||Sell||58,405||$47.61||$2,780,662.05||17,189|| |
|2/6/2014||Mark Andrekovich||Insider||Sell||4,302||$50.01||$215,143.02||38,135|| |
|1/2/2014||Peter Pond||Director||Sell||12,746||$42.86||$546,293.56|| |
|12/23/2013||Mark Andrekovich||Insider||Sell||4,303||$43.68||$187,955.04||44,701|| |
|12/16/2013||Mark Andrekovich||Insider||Sell||2,705||$43.62||$117,992.10||50,036|| |
|12/11/2013||Paul Lederer||Director||Sell||1,700||$43.94||$74,698.00||97,081|| |
|12/6/2013||Akbar Piloti||Insider||Sell||3,277||$45.05||$147,628.85||13,878|| |
|12/2/2013||Peter Pond||Director||Sell||12,746||$45.55||$580,580.30|| |
|11/26/2013||Mark Andrekovich||Insider||Sell||2,921||$45.59||$133,168.39||52,855|| |
|11/1/2013||Peter Pond||Director||Sell||12,748||$47.84||$609,864.32|| |
|10/3/2013||David Francis||General Counsel||Sell||17,000||$46.32||$787,440.00||15,378|| |
|9/3/2013||Peter Pond||Director||Sell||12,748||$37.36||$476,265.28|| |
|8/1/2013||Peter Pond||Director||Sell||12,748||$37.64||$479,834.72|| |
|7/8/2013||Peter Pond||Director||Sell||12,748||$36.44||$464,537.12|| |
|7/1/2013||Russell A Beliveau||Director||Sell||1,000||$37.77||$37,770.00|| |
|5/23/2013||Richard A Montoni||CEO||Sell||18,612||$74.23||$1,381,568.76|| |
|5/16/2013||David Francis||General Counsel||Sell||2,200||$77.92||$171,424.00|| |
|4/11/2013||Richard A Montoni||CEO||Sell||21,098||$79.27||$1,672,438.46|| |
|10/3/2012||David Francis||General Counsel||Sell||12,000||$59.92||$719,040.00|| |
Maximus (NYSE MMS) News Headlines
Maximus (NYSE:MMS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Maximus (NYSE:MMS) Income Statement, Balance Sheet and Cash Flow Statement
Maximus (NYSE MMS) Stock Chart for Sunday, May, 27, 2018